TCL Archive FDA approves a new cancer drug, Vidaza, and two sNDAs, without going to ODAC. A date with ODAC may signal a weak case for drug approval, recent approval data indicate. May 28, 2004
TCL Archive In Brief: Taxol Development Is NCI ‘Emergency Priority’, Dodd To Focus ACS Effort On Breast Screening December 7, 1990
TCL Archive Pharmacia Says SU5416 Doesn’t Benefit Colorectal Cancer Patients, Closes Trial. March 1, 2002
